ALNOV:EPA
Novacyt SA
0,44 €
0,00%
(0,00) 1D
19 նոյ, 17:35:19 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,44 €
High
0,45 €
Low
0,44 €
Mkt. cap
33,30 մլն
Avg. vol.
136,90 հզր
Volume
94,87 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 մլն
No. of employees
228
Open
0,44 €
High
0,45 €
Low
0,44 €
Mkt. cap
33,30 մլն
Avg. vol.
136,90 հզր
Volume
94,87 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 մլն
No. of employees
228
News stories
From web sources and news partners
ChartMill
·
1 ժամ առաջ
S&P 500 Top Movers: Gainers and Losers Today
FXStreet
·
16 րոպե առաջ
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Investing.com
·
8 րոպե առաջ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.19%
Traders Union
·
1 ժամ առաջ
Caleb Franzen: S&P 500 performance and AI stocks diverged under Powell and Warsh
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006 թ. հլս 3
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com